Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway

Tumor metastasis is the most lethal and debilitating process that threatens cancer patients. Among the regulators involved in tumor metastasis, lysyl oxidase (LOX) is an important contributor for tumor invasion, migration and the formation of the pre-metastatic niche. Although the relationship betwe...

Cijeli opis

Bibliografski detalji

Glavni autori:	Xiaoying Hou, Hongzhi Du, Xingping Quan, Lei Shi, Qianqian Zhang, Yao Wu, Yang Liu, Jing Xiao, Yong Li, Ligong Lu, Xun Ai, Meixiao Zhan, Shengtao Yuan, Li Sun
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2018-02-01
Serija:	Frontiers in Pharmacology
Teme:	lysyl oxidase EGFR silibinin NSCLC metastasis
Online pristup:	http://journal.frontiersin.org/article/10.3389/fphar.2018.00021/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!